42 related articles for article (PubMed ID: 22093061)
1. Acute humoral rejection in pediatric renal transplant recipients receiving steroid minimization immunosuppression.
Butani L; Gallay BJ
Pediatr Transplant; 2012 May; 16(3):269-73. PubMed ID: 22093061
[TBL] [Abstract][Full Text] [Related]
2. Extended experience with a steroid minimization immunosuppression protocol in pediatric renal transplant recipients.
Lau KK; Berg GM; Schjoneman YG; Perez RV; Butani L
Pediatr Transplant; 2010 Jun; 14(4):488-95. PubMed ID: 19849807
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
5. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data.
Hamiwka LA; Burns A; Bell L
Pediatr Transplant; 2006 May; 10(3):337-44. PubMed ID: 16677358
[TBL] [Abstract][Full Text] [Related]
6. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
7. Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: a randomized prospective study.
Park JB; Kim SJ; Oh HY; Han YS; Kim DJ; Park JW; Kwon CH; Joh JW; Lee SK
Transpl Int; 2006 Jun; 19(6):478-84. PubMed ID: 16771869
[TBL] [Abstract][Full Text] [Related]
8. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
[TBL] [Abstract][Full Text] [Related]
9. Potential influence of tacrolimus and steroid avoidance on early graft function in pediatric renal transplantation.
Li L; Weintraub L; Concepcion W; Martin JP; Miller K; Salvatierra O; Sarwal MM
Pediatr Transplant; 2008 Sep; 12(6):701-7. PubMed ID: 18179640
[TBL] [Abstract][Full Text] [Related]
10. Inadequate mycophenolic acid exposure and acute rejection in kidney transplantation.
Sánchez-Fructuoso AI; de la Higuera MA; Giorgi M; Ramos F; Garcia Ledesma P; Calvo N; Pérez-Flores I; Barrientos A
Transplant Proc; 2009; 41(6):2104-5. PubMed ID: 19715844
[TBL] [Abstract][Full Text] [Related]
11. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
Hoitsma AJ; Hilbrands LB
Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
[TBL] [Abstract][Full Text] [Related]
12. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
14. Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation.
Langer RM; Hené R; Vitko S; Christiaans M; Tedesco-Silva H; Ciechanowski K; Cassuto E; Rostaing L; Vilatoba M; Machein U; Ulbricht B; Junge G; Dong G; Pascual J
Transpl Int; 2012 May; 25(5):592-602. PubMed ID: 22471345
[TBL] [Abstract][Full Text] [Related]
15. Rapid steroid discontinuation for pediatric renal transplantation: a single center experience.
Lau KK; Haddad MN; Berg GM; Perez RV; Butani L
Pediatr Transplant; 2007 Aug; 11(5):504-10. PubMed ID: 17631018
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
[TBL] [Abstract][Full Text] [Related]
17. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
Tönshoff B; David-Neto E; Ettenger R; Filler G; van Gelder T; Goebel J; Kuypers DR; Tsai E; Vinks AA; Weber LT; Zimmerhackl LB
Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients.
Corman SL; Coley KC; Schonder KS
Pharmacotherapy; 2006 Oct; 26(10):1433-7. PubMed ID: 16999653
[TBL] [Abstract][Full Text] [Related]
19. A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen.
Han DJ; Park JB; Kim YS; Kim SJ; Ha J; Kim HC; Kim SJ; Moon IS; Yang CW
Transplant Proc; 2012 Jan; 44(1):115-7. PubMed ID: 22310592
[TBL] [Abstract][Full Text] [Related]
20. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
